Answers are grounded in this paper and cite their sources.
Machine learning enhances lead optimization in drug design, suggesting improved methods for targeting specific receptor classes.
DeepFrag2, a machine-learning tool for lead optimization via fragment addition, is more accurate when trained on fragments with specific sizes, charge states, or aromaticity. Fine-tuning on specific receptor classes further boosts performance.
No takes yet. Share an insight, caveat, or question.
Garcia-Jacas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: